KY02111
KY02111 is a canonical WNT signaling (β-catenin) inhibitor which promotes differentiation of hPSCs to cardiomyocytes. KY02111 can be used for the research of human cardiomyocyte regeneration[1].
Product Specifications
CAS Number
1118807-13-8
UNSPSC
12352005
Hazard Statement
H302
Target
Wnt
Type
Reference compound
Related Pathways
Stem Cell/Wnt
Applications
Cancer-programmed cell death
Field of Research
Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/ky02111.html
Purity
99.23
Solubility
DMSO : 33.33 mg/mL (ultrasonic)
Smiles
O=C(NC1=NC2=CC=C(Cl)C=C2S1)CCC3=CC=C(OC)C(OC)=C3
Molecular Formula
C18H17ClN2O3S
Molecular Weight
376.86
Precautions
H302
References & Citations
[1]Minami I, et al. A small molecule that promotes cardiac differentiation of human pluripotent stem cells under defined, cytokine- and xeno-free conditions. Cell Rep. 2012 Nov 29;2 (5) :1448-60.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1199053-01 0.02 mg (E-Coli)
Recombinant Rat Hematopoietic prostaglandin D synthase (Hpgds)
Sign In for Pricing
View Details MBS1199053-02 0.1 mg (E-Coli)
Recombinant Rat Hematopoietic prostaglandin D synthase (Hpgds)
Sign In for Pricing
View Details MBS1199053-03 0.02 mg (Yeast)
Recombinant Rat Hematopoietic prostaglandin D synthase (Hpgds)
Sign In for Pricing
View Details MBS1199053-04 0.1 mg (Yeast)
Recombinant Rat Hematopoietic prostaglandin D synthase (Hpgds)
Sign In for Pricing
View Details